Dystrophy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

Dystrophy Stocks Recent News

Date Stock Title
May 7 BMY A Look at Pharma ETFs Post Q1 Earnings
May 7 WVE Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
May 7 IONS Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
May 7 IONS Ionis Pharmaceuticals GAAP EPS of -$0.98 beats by $0.09, revenue of $119M misses by $17.41M
May 7 IONS Ionis reports first quarter 2024 financial results
May 6 BMY FDA accepts Bristol Myers application for injected Opdivo
May 6 IONS Ionis Pharmaceuticals Q1 2024 Earnings Preview
May 6 IONS Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
May 6 FULC Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET
May 6 BMY U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
May 6 BMY European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
May 5 SRPT Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 4 BMY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 DYN We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
May 4 DYN Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
May 3 SRPT Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Dystrophy

Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

Browse All Tags